Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 29;1(2):190-199.
doi: 10.1016/j.jdin.2020.09.001. eCollection 2020 Dec.

Impact of a hidradenitis suppurativa patient decision aid on treatment decision making: A randomized controlled trial

Donna McLean  1 , Olivia McBride  1 , Tanja Samardzic  2 , Mia Sisic  1   3 , Robert P Dellavalle  4   5   6 , Jerry Tan  1   3   7
Affiliations

Impact of a hidradenitis suppurativa patient decision aid on treatment decision making: A randomized controlled trial

Donna McLean et al. JAAD Int. .

Abstract

Background: Patient decision aids are tools that facilitate shared decision making when clinical evidence and patient values and preferences inform the process. Evidence-based guidelines have been developed for clinicians in hidradenitis suppurativa management. To address treatment decision-making needs of hidradenitis suppurativa patients, we developed a hidradenitis suppurativa patient decision aid.

Objective: To assess the efficacy of the hidradenitis suppurativa patient decision aid during treatment decision making.

Methods: An online, participant-blinded, parallel-group, randomized controlled trial of the hidradenitis suppurativa patient decision aid versus Mayo Clinic hidradenitis suppurativa website content (Mayo) was conducted with hidradenitis suppurativa patients. Outcomes were knowledge, decisional conflict, and preparation for decision making.

Results: Forty participants fulfilled inclusion criteria and were randomized to hidradenitis suppurativa patient decision aid or Mayo. In the hidradenitis suppurativa patient decision aid group, data from 16 and 15 participants were analyzed at phases 1 and 2, respectively. In the Mayo group, data from 15 and 13 participants were analyzed at phases 1 and 2, respectively. Increased knowledge (P < .01) and preparation for decision making (P < .01), as well as reduced decisional conflict (P < .01), were observed in the hidradenitis suppurativa patient decision aid compared with the Mayo group.

Limitations: The online methodology and recruitment from online hidradenitis suppurativa support groups limits generalizability of findings.

Conclusion: A hidradenitis suppurativa patient decision aid increased knowledge and preparation for decision making and reduced decisional conflict.

Keywords: CI, confidence interval; SD, standard deviation; decisional conflict; hidradenitis suppurativa; patient decision aid; patient knowledge; randomized controlled trial; shared decision making.

PubMed Disclaimer

Figures

Fig 1
Fig 1
A hidradenitis suppurativa patient decision aid versus Mayo Clinic hidradenitis suppurativa website. HS-PDA, Hidradenitis suppurativa patient decision aid.
Fig 2
Fig 2
Changes in hidradenitis suppurativa–related knowledge and decisional conflict by group over time. Brackets denote significant changes between same measures. ∗P ≤ .05. ∗∗P ≤ .01. ∗∗∗P ≤ .001. HS-PDA, Hidradenitis suppurativa patient decision aid.
See this image and copyright information in PMC

References

    1. Forrow L., Wartman S.A., Brock D.W. Science, ethics, and the making of clinical decisions. Implications for risk factor intervention. JAMA. 1988;259(21):3161–3167. - PubMed
    1. Politi M.C., Wolin K.Y., Légaré F. Implementing clinical practice guidelines about health promotion and disease prevention through shared decision making. J Gen Intern Med. 2013;28(6):838–844. - PMC - PubMed
    1. Stacey D., Légaré F., Col N.F. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4(4):CD001431. - PMC - PubMed
    1. Riis P.T., Vinding G.R., Ring H.C., Jemec G.B. Disutility in patients with hidradenitis suppurativa: a cross-sectional study using EuroQoL-5D. Acta Derm Venereol. 2016;96(2):222–226. - PubMed
    1. Gooderham M., Papp K. The psychosocial impact of hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5 suppl 1):S19–S22. - PubMed

LinkOut - more resources